ADSX Applied Digital Solutions (MM)

Number of infant protection systems sold to new customers in first quarter 2007 up 28 percent year over year DELRAY BEACH, Fla., April 18 /PRNewswire-FirstCall/ -- VeriChip Corporation (NASDAQ:CHIP), a provider of RFID systems for healthcare and patient-related needs, announced today that it has sold its 1,200th RFID-based system for the protection of newborn infants and pediatric patients. This includes systems sold under the Hugs(R), HALO(R) and MyChild(R) brands. VeriChip's infant protection systems are designed to prevent infant abductions and inadvertent child mishandlings. The main component of the systems is a wearable RFID tag that is assigned to child and mother following birth. Monitors positioned throughout the hospital detect the integrity of the tags and location of the child. If a newborn is removed from the ward, if the tag is lifted from the baby's skin or if the ankle strap is compromised, the system immediately triggers an alarm, alerting hospital security to the situation. The VeriChip infant protection systems also guard against mismatching events by affixing matching RFID tags to mother and child. If the mother is given the wrong child, the RFID tag detects the mismatch and activates an audible alarm. VeriChip believes that it has the largest installation base of infant protection systems of any company in the industry. In the first quarter of 2007, the number of infant protection systems sold by VeriChip increased 14 percent, while the number of infant protection systems sold to new customers increased 28 percent compared to the first quarter of 2006. "This is an important milestone for our healthcare security business," said Scott R. Silverman, Chairman and Chief Executive Officer of VeriChip. "The market for infant protection continues to grow at a rapid pace as hospitals and parents push for improvements in hospital security. As a result, systems like Hugs and HALO, which are proven effective at safeguarding against infant abductions, are increasingly becoming the gold standard at most birthing hospitals and a key factor for parents in determining where they choose to have their child." For more information on VeriChip's healthcare security products, please contact 1-866-559-6275 or email . Additional information can be found online at http://www.verichiphealthcare.com/. About VeriChip Corporation VeriChip Corporation, headquartered in Delray Beach, Florida, develops, markets and sells radio frequency identification, or RFID, systems used to identify, locate and protect people and assets. VeriChip's goal is to become the leading provider of RFID systems for people in the healthcare industry. VeriChip sells passive RFID systems for identification purposes and active RFID systems for local-area location and identification purposes. VeriChip recently began to market its VeriMed(TM) Patient Identification System for rapidly and accurately identifying people who arrive in an emergency room and are unable to communicate. This system uses the first human-implantable passive RFID microchip, the implantable VeriChip(TM), cleared for medical use in October 2004 by the United States Food and Drug Administration. VeriChip Corporation is majority-owned by Applied Digital Inc. (NASDAQ:ADSX), which also owns a majority position in Digital Angel Corporation (AMEX:DOC). For more information on VeriChip, please call 1-800-970-2447, or email . Additional information can be found online at http://www.verichipcorp.com/. Statements about the Company's future expectations, including future revenues and earnings, and all other statements in this press release other than historical facts are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and the Company's actual results could differ materially from expected results. The Company undertakes no obligation to update forward-looking statements to reflect subsequently occurring events or circumstances. Contact: VeriChip Corporation Allison Tomek 561-805-8000 The Ruth Group Nick Laudico (investors) (646) 536-7030 Jason Rando (media) (646) 536-7025 DATASOURCE: VeriChip Corporation CONTACT: Allison Tomek, VeriChip Corporation, +1-561-805-8000, ; or investors, Nick Laudico, +1-646-536-7030, , or media, Jason Rando +1-646-536-7025, , both of The Ruth Group Web site: http://www.verichipcorp.com/ http://www.verichiphealthcare.com/

Copyright